Mutations in the TP53 tumor suppressor gene occur in 50% of lung adenocarcinoma and associate with a poor prognosis, but…
Nature
Today, the journals Nature and Nature Genetics publish two studies led by Dr Francisco Martínez Jiménez, current head of VHIO’s…